CLINICAL_TRIALS
trial_result
· 2022-07-07
Clinical Trial Update: Safety and Effectiveness of Delamanid-containing Regimen for MDR-TB Patients in China [Phase 4]
Summary
Phase 4 trial update assessing safety and effectiveness of a delamanid-containing regimen for multidrug-resistant tuberculosis in China.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Beijing Chest Hospital | Conditions: Multidrug Resistant Tuberculosis | Phase 4 | Status: UNKNOWN